| 摘要 |
The invention concerns a novel pharmaceutical agent which comprises a new crystalline form of a substituted quinoline derivative (defined herein) which is a potent antagonist of angiotensin AII and of use in treating conditions such as hypertension, congestive heart disease or hyperaldosteronism. A process for the production of the novel crystalline form and pharmaceutical compositions containing it are also included. |
